SPOTLIGHT -
Relapse in MDD is associated with morphologic brain changes; stopping exercise may increase depressive symptoms; and inflammatory biomarkers may predict which treatment-resistant MDD patients benefit from ECT.
Topline Phase 2 Data Support Efficacy, Tolerability, and Favorable Safety of Treatment for PTSD
Blue Light Blockers: A Behavior Therapy for Mania
Non-Psychiatric Medications With Potential to Worsen Symptoms in Major Depression
Blue Light, Depression, and Bipolar Disorder
Phase 3 Study Supports Efficacy, Safety of New Chemical Entity for MDD
Psilocybin Plus SSRIs for Treatment-Resistant Major Depression